Acacia Research CorporationQ2 results boosted by $60.6M Wi-Fi 6 licensing settlement and record revenue from Cherokee production.

Acacia Research Corporation reported second-quarter 2026 results bolstered by a $60.6 million Wi-Fi 6 licensing settlement, which was booked as accounts receivable at quarter-end with cash received in the third quarter. The settlement was subject to significant contractual splits with partners and contingency counsel. Benchmark delivered record revenue supported by the start of production from the Cherokee development, while Deflecto is undergoing manufacturing optimization to position for profitable growth as demand improves. The company recorded a $3.7 million non-recurring legal expense related to legacy litigation and a full write-down of its investment in MalinJ1 due to liquidity issues at Mycovia Pharmaceuticals. Acacia maintains a debt-free parent balance sheet and is exploring a potential transaction to gain direct ownership in Mycovia ahead of upcoming FDA milestones.
Acacia Research CorporationQ2 results boosted by $60.6M Wi-Fi 6 licensing settlement and record revenue from Cherokee production.
Full write-down of investment in MalinJ1 due to liquidity issues at Mycovia Pharmaceuticals.
Deflecto undergoing manufacturing optimization to position for profitable growth as demand improves.